Arguably Wall Street’s most pessimistic voice has been so surprised by the market rally that he is questioning the firm’s own corporate earnings model.
Kelley Blue Book: Why the feds are fighting with this state over a car repair law
The battle over who can see data about your car is getting weird. NHTSA is telling automakers not to comply one state’s ‘right to repair law.’
NerdWallet: Do you really need an MBA? Here are some ways to get business skills without the steep price tag.
The cost of an MBA can be high, and acceptance rates are low. If you want access to business school education without the price and hassle, you have options.
NerdWallet: New college grads: Start your financial life on the right foot with these 6 tips from experts
Finding your budget style, protecting your credit, starting a savings plan and factoring in taxes are a few ways you can set yourself up for fiscal fitness.
Next Avenue: Do you want to regain the physical and mental powers of your 20s? Here’s what to know about brain implants before you say ‘yes.’
Can a brain implant help you regain your youth? What would give up for that? With neural implants, science fiction is becoming reality.
Livability: The best affordable little cities to live in America
These are the kind of small cities where most Americans create dream careers, build families, launch businesses and lead meaningful lives. Here’s 20 of the best
Next Avenue: How to plan a fun and memorable trip with your grandkids
Having a great time while traveling with kids takes planning, awareness and communication. Try these tips for a fun and rewarding trip for all generations.
Market Snapshot: Dow ends down 200 points as investors eye Powell’s comments Wednesday
U.S. stocks closed lower Tuesday, trimming last week’s gains which took indexes to the highest levels in more than a year, as investors await testimony from Federal Reserve chair Jerome Powell to Congress this week as data suggests the economy remains healthy.
Financial News: UBS faces hundreds of millions in fines over Credit Suisse’s Archegos: report
Credit Suisse’s relationship with family office Archegos Capital is set to hit UBS following investigations by UK, Swiss and US regulators.
: Hit Wegovy weight-loss drug on track for $4 billion in U.S. sales despite supply constraints, analyst says
The hit Wegovy weight-loss drug is on track for sales of over $4 billion this year in the U.S. alone, despite its manufacturer Novo Nordisk struggling to keep up with demand.
- « Previous Page
- 1
- …
- 516
- 517
- 518
- 519
- 520
- …
- 1275
- Next Page »